EQS-Adhoc: Fresenius Medical Care AG & Co. KGaA: Ms. Helen Giza appointed as new CEO of the Management Board; Dr. Carla Kriwet agreed to resign as CEO and member of the Management Board
|
EQS-Ad-hoc: Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel
Today, the Supervisory Board of Fresenius Medical Care Management AG, the General Partner of Fresenius Medical Care AG & Co. KGaA, has unanimously appointed Ms. Helen Giza as CEO of the Management Board with effect as of the beginning of December 6, 2022. Ms. Helen Giza remains also acting Chief Financial Officer of Fresenius Medical Care until a successor has been found. In addition, the Supervisory Board of Fresenius Medical Care Management AG has accepted the offer by Dr. Carla Kriwet to resign as CEO and member of the Management Board with effect as of the end of December 5, 2022 before.
In her capacity as CEO of Fresenius Medical Care, Ms. Helen Giza will also be a member of the Management Board of Fresenius Management SE. Dr. Carla Kriwet also has resigned as a member of the Management Board of Fresenius Management SE. Contact: Dr. Dominik Heger EVP & Head of Investor Relations, Strategic Development & Communications [email protected] Tel. +49 6172 609 2601
05-Dec-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Fresenius Medical Care AG & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Phone: | +49 (0) 6172- 609 2525 |
| Fax: | +49 (0) 6172- 609 2301 |
| E-mail: | [email protected] |
| Internet: | www.freseniusmedicalcare.com |
| ISIN: | DE0005785802 |
| WKN: | 578580 |
| Indices: | DAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; NYSE, Luxembourg Stock Exchange |
| EQS News ID: | 1505583 |
| End of Announcement | EQS News Service |
|
|
1505583 05-Dec-2022 CET/CEST
Fresenius Medical Care AG & Co KGaA ST Aktie
35,78 €
-0,08 %
Bei der Aktie stehen derzeit 4 Buy-Einschätzungen 0 Sell-Einschätzungen gegenüber. Das Sentiment ist also durchaus positiv.
Für Fresenius Medical Care AG & Co KGaA ST sieht die Community ein Kursziel von 50 €, was eine erhebliche Steigerung um über 20% gegenüber dem aktuellen Kurs von 35.78 € bedeutet.
